骨代谢营养学实验中OPG/ＲANK/ＲANKL系统综述(3)

　　4总结
　　
　　OPG / RANK / RANKL系统是近年来骨科学研究的重大发现，不仅为骨代谢疾病发病机制和治疗手段的研究开辟了新方向，也为骨骼营养方法学研究提供了一种全新思路。OPG/RANK/RANKL系统在骨骼营养学研究中应用的不断完善，必将为营养学研究带来广阔的前景。
　　
　　参考文献：
　　[1] 付强，刘源。钙、磷与维生素D对动物骨代谢的影响研究进展[J].中国比较医学杂志，2006,16（8） :502 - 505.
　　[2]Morinaga T,Nakagawa N,Y asuda H,et al. Cloning andcharacterization of the gene encoding human osteoprotegerin /osteoclasto-genesis inhibitory factor[J]. Eur J Biochem,1998,254:685.
　　[3]Yun TJ,Chaudhary PM,Shu GL,et al. OPG/FDCR-1,a TNFreceptor family member,is expressed in lymphoid cells and is up-regulated by ligating CD40[J]. J Immunol,1998,161（11） :6113 - 6121.
　　[4]Simonet WS,Lacey D,Dunstan C,et al. Osteoprogerin:a novelsecreted protein involved in the regulation of bone density[J].Cell,1997,89:309 - 319.
　　[5]Yamaguchi K,Kinosaki M,Goto M,et al. Characterization ofstructural domains of human osteoclastogenesis inhibitory factor[J]. J Biochem,1998,273（9） :5117 - 5123.
　　[6]Kanazawa K,Kudo A. Self-assembled RANK inducesosteoclastogenesis ligand-independently[J]. J Bone Miner Res.2005,20（11） :2053 - 2060.
　　[7]Galibert L,Tometsko ME,Anderson DM,et al. Theinvolvement of multiple tumor necrosis factor receptor（TNFR）-associated factors in the signaling mechanisms of receptoractivator of NF-kappa B,a member of the TNFR superfamily[J].J Biol Chem. 1998,273（51） :34120 - 34127.
　　[8]Ye H,Arron JR,Lamothe B,Cirilli M,et al. Dis-tinctmolecular mechanism for initiating TRAF6 signalling[J].Nature,2002,418（6896） :443 - 447.
　　[9]Silva I,Branco JC. Rank/Rankl/opg:literature review[J].Acta Reumatol Port,2011,36（3） :209 - 218.
　　[10] 姚静，侯加法。 OPG/RANKL/RANK系统的研究进展[J].动物医学进展，2006,27（2） :5 - 9.
　　[11]Boyce BF. Advances in the regulation of osteoclasts andosteoclast functions[J]. J Dent Res,2013,92（10） :860 - 867.
　　[12]Anderson DM,Maraskovsky E,Billingsley WL,et al. Ahomologue of the TNF receptor and its ligand enhance T-cellgrowth and dendritic-cell functio[J]. Nature,1997,390（6656） :175 - 179.
　　[13]Wong BR,Josien R,Lee SY,et al. TRANCE（tumor necrosisfactor[TNF]-related activation-induced cytokine） ,a new TNFfamily member predominantly expressed in T cells,is a dendriticcell-specific survival factor[J]. J Exp Med,1997,186（12） :2075 - 2080.
　　[14]Ikeda T,Kasai M,Suzuki J,et al. Multimerization of thereceptor activator of nuclear factor-kappa B ligand（RANKL）isoforms and regulation of osteoclastogenesis[J]. J Biol Chem,2003,278（47） :47217 - 47222.
　　[15]Patrick Garnero. New developments in biological markers of bonemetabolism in osteoporosis[J]. Bone,2014,66:46 - 55.
　　[16]Damaris Vega,Naim M. Maalouf,The Role of ReceptorActivator of Nuclear Factor-B（RANK）/ RANK Ligand /Osteoprotegerin:Clinical Implications[J]. The Journal ofClinical Endocrinology & Metabolism,2007,92（12） :4514- 4521.
　　[17]Bucay N,Sarosi I,Dunstan CR,et al. Osteoprotegerin-deficientmice develop early onset osteoporosis and arterial calcification[J]. Genes Dev,1998,12（9） :1260 - 1268.
　　[18]Hughes AE,Ralston SH,Marken J,et al. Mutations inTNFRSF11 A,affecting the signal peptide of RANK,causefamilial expansile osteolysis[J]. Nat Genet,2000,24（1） :45 -48.
　　[19]Whyte MP,Obrecht SE,Finnegan PM,et al. Osteoprotegerindeficiency and juvenile Paget 's disease[J]. N Engl J Med,2002,347（3） :175 - 184.
　　[20]Eghbali-Fatourechi G,Khosla S,Sanyal,et al. Role of RANKligand in mediating increased bone resorption of in earlypostmenopausal women[J]. Clin Invest,2003,111（8） :1120- 1122.
　　[21] 王建杰，罗文哲，齐建祥，等。川芎嗪对类风湿关节炎模型大鼠关节滑液RANK/RANKL/OPG表达的影响[J].中国老年学杂志，2011,31:833 - 835.
　　[22]Locklin RM,Khosla S,Riggs BL. Mechanisms of biphasicarrabolic and catabolic effects of parathyroid hormone（PTH）onbone cells[J]. Bone,2001,28（Suppl） :80.
　　[23] 王建忠，王坤正，时志斌，等。长期应用糖皮质激素对大鼠股骨头骨组织OPG/RANKL mRNA表达的影响[J].西安交通大学学报（ 医学版） ,2008,12（6） :629 - 632.
　　[24]Shu-Jem Su,Yao-Tsung Yeh,Huey-Wen Shyu. The PreventiveEffect of Biochanin A on Bone Loss in Ovariectomized Rats:Involvement in Regulation of Growth and Activity of Osteoblastsand Osteoclasts[J / OL]. Evidence-Based Complementary andAlternative Medicine,2013,Article ID 594857,10 pages.http:/ / dx. doi. org /10. 1155 /2013 /594857.
　　[25] 冯建书，付强，闫世杰，等。仙灵骨葆对骨质疏松大鼠OPG/RANK / RANKL表达的影响[J].现代生物医学进展，2012,12（23） :4438 - 4441.
　　[26] 赵智力，王洪荣。评定反刍动物钙、磷营养需要的指标[J].畜牧与饲料科学，2005,4:14 - 16.
　　[27] 俞路，王雅倩，章世元。动物钙营养代谢的基因调控探讨[J].猪与禽，2007,27（4） :61 - 62.
　　[28]L. C. Hofbauer,C. A. Kühne,V. Viereck. The OPG/RANKL/RANK system in metabolic bone diseases[J]. J MusculoskelNeuron Interact,2004,4（3） :268 - 275.
　　[29]Shin-ichi Katsumata,Ritsuko Masuyama,Mariko Uehara,et al.High-phosphorus diet stimulates receptor activator of nuclearfactor-k B ligand mRNA expression by increasing parathyroidhormone secretion in rats[J]. British Journal of Nutrition,2005,94,666 - 674.
　　[30]Dan LM,Yang AW,Guo BL,et al. Upregulates the Expressionof Osteoprotegerin in Mouse Osteoblasts MC3T3-E1 ThroughPKC / MAPK Pathways[J]. Biol Trace Elem Res,2012,146:340 - 348.
　　[31]Spyridon Kanellakis,George Moschonis,Roxane Tenta,et al.Changes in Parameters of Bone Metabolism in PostmenopausalWomen Following a 12-Month Intervention Period Using DairyProducts Enriched with Calcium,Vitamin D,and Phylloquinone（Vitamin K1）or Menaquinone-7（Vitamin K2） :ThePostmenopausal Health Study II[J]. Calcif Tissue Int,2012,90:251 - 262.